Stock BIIB BIOGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Biogen Inc.

Equities

BIIB

US09062X1037

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
225.4 USD -2.83% Intraday chart for Biogen Inc. +0.22% -12.88%
Jun. 06 US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug RE
Jun. 06 Wedbush Adjusts Price Target on Biogen to $215 From $219 MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP
PR
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses to Contact the Firm
BU
US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug
RE
Wedbush Adjusts Price Target on Biogen to $215 From $219
MT
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe
DJ
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB
PR
Novartis and others face Italy antitrust probe over eye drug
RE
Transcript : Biogen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 12:30 PM
FINAL DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
PR
Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class Action - BIIB
PR
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)
BU
Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join - Contact Levi & Korsinsky
PR
Robbins LLP Urges BIIB Investors With Large Losses to Contact the Firm for Information About the Biogen Inc. Class Action
BU
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)
BU
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
GL
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
AQ
NASDAQ: BIIB: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Biogen Inc.
BU
Biogen: Brussels grants marketing authorization for Charcot disease
CF
Disaster averted
Our Logo
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIIB Stock
  4. News Biogen Inc.